ARM Investor Relations website

ARM Investor Relations website

Print this page

Bookmark this Page

Consolidated cash flow statement

For the year ended 31 December

 

 

Note

2009
£000

2008
£000

Operating activities

 

 

 

Profit from operations

 

45,614

59,943

Adjustments for:

 

 

 

Depreciation and amortisation of tangible and intangible assets

 

24,953

26,952

Loss on disposal of property, plant and equipment

 

79

36

Compensation charge in respect of share-based payments

 

19,001

15,409

Impairment of available-for-sale investments

 

412

Profit on disposal of available-for-sale investments

 

(224)

Provision for doubtful debts

 

1,018

641

Provision for obsolescence of inventories

 

211

87

Movement in fair value of currency exchange contracts

 

(18,914)

17,961

Movement in fair value of embedded derivatives

 

9,818

(12,518)

Changes in working capital

 

 

 

Accounts receivable

 

9,531

(6,364)

Inventories

 

 81

280

Prepaid expenses and other assets

 

358

(8,915)

Accounts payable

 

(4,673)

4,661

Deferred revenue

 

10,281

1,548

Accrued and other liabilities

 

14,564

6,831

Cash generated by operations before tax

 

112,110

106,552

Income taxes paid

 

(15,550)

(6,019)

Net cash from operating activities

 

96,560

100,533

Investing activities

 

 

 

Interest received

 

1,277

3,234

Purchases of property, plant and equipment

14

(6,030)

(8,084)

Purchases of other intangible assets

 

(3,888)

(5,938)

Purchases of available-for-sale investments

13

(9,116)

(1,029)

Proceeds on disposal of available-for-sale investments

 

663

6,291

Proceeds on disposal of property, plant and equipment

 

49

Purchase of short-term investments

 

(104,902)

(758)

Purchase of subsidiaries, net of cash acquired*

 

(563)

(7,371)

Net cash used in investing activities

 

(122,510)

(13,655)

Financing activities

 

 

 

Proceeds received on issuance of shares from treasury

 

19,085

5,581

Purchase of own shares

20

(40,286)

Dividends paid to shareholders

7

(28,961)

(26,383)

Net cash used in financing activities

 

(9,876)

(61,088)

Net (decrease)/increase in cash and cash equivalents

 

(35,826)

25,790

Cash and cash equivalents at beginning of the year

 

76,502

49,509

Effect of foreign exchange rate changes

 

(6,187)

1,203

Cash and cash equivalents at end of the year

9

34,489

76,502

*The aggregate cash outflow for purchase of subsidiaries in 2009 was £563,000 (2008: £7,387,000) and net cash acquired was £nil (2008: £16,000).

The accompanying notes are an integral part of the financial statements.